Cargando…
Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation
The chromosomal t(4;14) (p16;q32) translocation drives high expression of histone methyltransferase nuclear SET domain–containing 2 (NSD2) and plays vital roles in multiple myeloma (MM) evolution and progression. However, the mechanisms of NSD2-driven epigenomic alterations in chemoresistance to pro...
Autores principales: | Wang, Jingjing, Zhu, Xu, Dang, Lin, Jiang, Hongmei, Xie, Ying, Li, Xin, Guo, Jing, Wang, Yixuan, Peng, Ziyi, Wang, Mengqi, Wang, Jingya, Wang, Sheng, Li, Qian, Wang, Yafei, Wang, Qiang, Ye, Lingqun, Zhang, Lirong, Liu, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843744/ https://www.ncbi.nlm.nih.gov/pubmed/35166240 http://dx.doi.org/10.1172/JCI149526 |
Ejemplares similares
-
Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma
por: Jiang, Hongmei, et al.
Publicado: (2022) -
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance
por: Li, Xin, et al.
Publicado: (2023) -
All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma
por: Peng, Ziyi, et al.
Publicado: (2023) -
Reprogramming of ovarian aging epigenome by resveratrol
por: Gou, Mo, et al.
Publicado: (2022) -
Temporospatial induction of homeodomain gene cut dictates natural lineage reprogramming
por: Xu, Ke, et al.
Publicado: (2018)